Pulse pressure, heart rate, and drug treatment of hypertension

Current Hypertension Reports

Volumn 6, Issue 3, 2004, Pages 190-194

  Safar, Michel E ^a  

^a HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIHYDRALAZINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE; PROPRANOLOL; SPIRONOLACTONE;

ANTIHYPERTENSIVE THERAPY; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; DRUG MECHANISM; HEART HEMODYNAMICS; HEART INFARCTION; HEART RATE; HUMAN; HYPERTENSION; NONHUMAN; PREDICTION; PRINCIPAL COMPONENT ANALYSIS; PULSE PRESSURE; REVIEW; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; BLOOD PRESSURE; DIASTOLE; DRUG EFFECT; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; RISK FACTOR; SYSTOLE;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DIASTOLE; HEART RATE; HUMANS; HYPERTENSION; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SYSTOLE;

EID: 4644252537     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-004-0068-7     Document Type: Review

References (50)

1. Kannel WB: Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1996, 24: 1571-1576.
2. Collins R, Peto R, Mac Mahon S, et al.: Blood pressure, stroke, and coronary heart disease: Part 2. Short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990, 335: 827-838.
3. Sagie A, Larson MG, Levy D: The natural history of borderline isolated systolic hypertension. N Engl J Med 1993, 329: 1912-1917.
4. Black HR: The paradigm has shifted to systolic blood pressure. Hypertension 1999, 34: 386-387.
5. Nichols WW, O'Rourke M: McDonald's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles, edn 4. London, Sydney, Auckland: Arnold; 1998:54-113, 201-222, 284-292, 347-401.
6. Abernethy J, Borhani NO, Hawkins CM, et al.: Systolic blood pressure as an independent predictor of mortality in the hypertension detection and follow-up program. Am J Prev Med 1986, 2: 123-132.
7. Dyer AR, Stamler J, Shekelle RB, et al.: Pulse pressure: III. Prognostic significance in four Chicago epidemiologic studies. J Chronic Dis 1982, 35: 283-294.
8. Prospective Studies Collaboration: Age-specific relevance of usual blood pressure to vascular mortality: one million adults in 61 prospective studies. Lancet 2002, 360: 1903-1913.
9. Darne B, Girerd X, Safar M, et al.: Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality. Hypertension 1989, 13: 392-400.
10. Madhavan S, Ooi WL, Cohen H, Alderman MH: Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension 1994, 23: 395-401.
11. Fang J, Madhavan S, Cohen H, Alderman MH: Measures of blood pressure and myocardial infarction in treated hypertensive patients. J Hypertens 1995, 13: 413-419.
12. Verdecchia P, Schillaci G, Borgioni C, et al.: Ambulatory pulse pressure: a potent predictor of total cardiovascular risk in hypertension. Hypertension 1998, 32: 983-988.
13. Staessen JA, Thijs L, O'Brien ET, et al.: Ambulatory pulse pressure as predictor of outcome in older patients with systolic hypertension. The Syst-Eur Trial Investigators. Am J Hypertens 2002, 15: 835-843.
14. Nakayama Y, Tsumura K, Yamashita N, et al.: Pulsatility of ascending aortic pressure waveform is a powerful predictor of restenosis after percutaneous transluminal angioplasty. Circulation 2000, 101: 470-472.
15. Safar ME, Blacher J, Pannier B, et al.: Central pulse pressure and mortality in end-stage renal disease. Hypertension 2002, 39: 735-738.
16. Franklin SS, Khan SA, Wong ND, et al.: Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 1999, 100: 354-360.
17. Millar JA, Lever AF, Burke V. Pulse pressure as a risk factor for cardiovascular events in the MRC mild hypertension trial. J Hypertens 1999, 17: 1065-1072.
18. Blacher J, Gasowski J, Staessen JA, et al.: Pulse pressure- not mean pressure - determines cardiovascular risk in older hypertensive patients. Arch Intern Med 2000, 160: 1085-1089.
19. Domanski MJ, Davis BR, Pfeffer MA, et al.: Isolated systolic hypertension, prognostic information provided by pulse pressure. Hypertension 1999, 34: 375-380.
20. Benetos A, Zureik M, Morcet J, et al.: A decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with high cardiovascular mortality. J Am Coll Cardiol 2000, 35: 673-680.
21. Franklin SS, Larson MG, Khan SA, et al.: Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation 2001, 103: 1245-1249.
22. Franklin SS, Gustin W IV, Wong ND, et al.: Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997, 96: 308-315.
23. Miura K, Dyer AR, Greenland P, et al.: Pulse pressure compared with other blood pressure indexes in the prediction of 25-year cardiovascular and all-cause mortality rates. The Chicago Heart Association Detection Project in Industry Study. Hypertension 2001, 38: 232-237.
24. Psaty BM, Furber GCD, Kuller LH, et al.: Association between blood pressure level and the risk of myocardial infarction, stroke and total mortality. The Cardiovascular Health Study. Arch Intern Med 2001, 161: 1183-1192.
25. Blacher J, Guerin A, Pannier B, et al.: Impact of aortic stiffness on survival in end-stage renal failure. Circulation 1999, 99: 2434-2439.
26. London GM, Blacher J, Pannier B, et al.: Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001, 38: 434-438.
27. Blacher J, Guerin A, Pannier B, et al.: Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001, 38: 938-942.
28. Albaladejo P, Copie X, Boutouyrie P, et al.: Heart rate, arterial stiffness and wave reflections in paced patients. Hypertension 2001, 38: 949-952.
29. Benetos A, Safar M, Rudnichi A, et al.: Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension 1997, 30: 1410-1415.
30. Alderman MH, Cohen H, Madhavan S: Distribution and determinants of cardiovascular events during 20 years of successful antihypertensive treatment. J Hypertens 1998, 16: 761-769.
31. Safar ME: Therapeutic trials and large arteries in hypertension. Am Heart J 1988, 115: 702-710.
32. Somes GW, Pahor M, Short RI, et al.: The role of diastolic blood pressure when treating isolated systolic hypertension. Arch Intern Med 1999, 159: 2004-2009.
33. The ALLHAT Officers and Coordinators of the ALLHAT Collaborative Research Group: Major outcome in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002, 288: 2991-2997.
34. Mourad JJ, Blacher J, Blin P, Warzocha U: Conventional antihypertensive drug therapy does not prevent the increase of pulse pressure with age. The Investigators of the PHASTE Study. Hypertension 2001, 38: 958-962.
35. Van Bortel LM, Struijker-Boudier HA, Safar ME: Pulse pressure, arterial stiffness, and drug treatment of hypertension. Hypertension 2001, 38: 914-921.
36. Asmar RG, London GM, O'Rourke ME, Safar ME: Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patients: a comparison with atenolol. The Reason Project Coordinators and Investigators. Hypertension 2001, 38: 922-926.
37. Blacher J, Amah G, Girerd X, et al.: Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension. Am J Hypertens 1997, 10: 1326-1334.
38. Lacolley P, Labat C, Pujol A, et al.: Increased carotid wall elastic modulus and fibronectin in aldosterone-salt treated rats: effects of eplerenone. Circulation 2002, 106: 2848-2853.
39. Kass DA, Shapiro EP, Kawaguchi M, et al.: Improved arterial compliance by a novel advanced glycation end-product cross-link breaker. Circulation 2001, 104: 1464-1470.
40. Palatini P, Julius S: Heart rate and the cardiovascular risk. J Hypertens 1997, 15: 3-17.
41. Bassiouny HS, Zarins CK, Kadowaki MH, Glagov S: Hemodynamic stress and experimental aortoiliac atherosclerosis. J Vasc Surg 1994, 19: 426-434.
42. Borer JS, Fox K, Jaillon P, Lerebours G: Antianginal and anti-ischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial. Circulation 2003, 107: 817-823.
43. Laurent P, Albaladejo P, Blacher J, et al.: Heart rate and pulse pressure amplification in hypertensive subjects. Am J Hypertens 2003, 16: 363-370.
44. Mitchell GF, Moye LM, Braunwald E, et al.: Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. The SAVE Investigators. Circulation 1997, 96: 4254-4260.
45. ChaE CU, Pfeffer MA, Glynn RJ, et al.: Increased pulse pressure and risk of heart failure in the elderly. JAMA 1999, 281: 634-639.
46. Franklin SS, Sutton-Tyrrell K, Belle SH, et al.: The importance of pulsatile components of hypertension in predicting carotid stenosis in older adults. J Hypertens 1997, 15: 1143-1150.
47. Totomouko JJ, Safar ME, Asmar RA, Laurent ST: Increased pulse pressure in patients with arteriosclerosis of the lower limbs. Arteriosclerosis 1987, 7: 232-237.
48. Cruickshank K, Riste L, Anderson SG, et al.: Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: An integrated index of vascular function? Circulation 2002, 106: 2085-2090.
49. Henry RM, Kostence PJ, Spijkerman AM, et al.: Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn Study. Circulation 2003, 107: 2089-2095.
50. London GM, Guerin AP, Pannier B, et al.: Large artery structure and function in hypertension and end-stage renal disease. J Hypertens 1998, 16: 1931-1938.